Skip to main content
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 191.76
Day High 198.00
Open:193.70
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Seagen Inc. is a biotechnology company. It discovers, develops and commercializes transformative cancer medicines. The company operates principally in California, Canada, Switzerland and the European Union. Seagen Inc., formerly known as Seattle Genetics Inc., is headquartered in the Seattle.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Seagen Announces Closing of $1.0 Billion Stock Sale to Merck
- BusinessWire - Wed Oct 28, 4:00AM CDT
BusinessWire - CMTX
Wed Oct 28, 4:00AM CDT
Seagen Inc. (Nasdaq: SGEN) today announced the closing of a $1.0 billion equity investment by Merck in 5.0 million newly-issued shares of Seagen common stock at a price of $200 per share. The closing occurred following expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). The investment was made in connection with a global collaboration with Merck to co-develop and commercialize ladiratuzumab vedotin, an investigational antibody-drug conjugate (ADC) targeting LIV-1, which is currently in clinical trials for breast cancer and other solid tumors.
Seattle Genetics Set to Possibly Rebound After Yesterday's Selloff of 1.32%
- Comtex SmarTrend(R) - Mon Oct 19, 12:36PM CDT
Comtex SmarTrend(R) - CMTX
Mon Oct 19, 12:36PM CDT
Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $197.54 to a high of $201.86. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $200.51 on volume of 129,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Seattle Genetics Up 25.1% Since SmarTrend Uptrend Call (SGEN)
- Comtex SmarTrend(R) - Fri Oct 16, 12:44AM CDT
Comtex SmarTrend(R) - CMTX
Fri Oct 16, 12:44AM CDT
SmarTrend identified an Uptrend for Seattle Genetics (NASDAQ:SGEN) on September 14th, 2020 at $163.78. In approximately 1 month, Seattle Genetics has returned 25.09% as of today's recent price of $204.87.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 187.00 +4.20% increase
on 09/29/20
Period Open:190.51
Price movement based on the high, low and last over the given period.
213.94 -8.92% decrease
on 10/13/20
+4.34 (+2.28%) increase
since 09/28/20
3-Month 143.61 +35.68% increase
on 09/04/20
Period Open:171.35
Price movement based on the high, low and last over the given period.
213.94 -8.92% decrease
on 10/13/20
+23.50 (+13.71%) increase
since 07/28/20
52-Week 90.57 +115.14% increase
on 03/16/20
Period Open:105.77
Price movement based on the high, low and last over the given period.
213.94 -8.92% decrease
on 10/13/20
+89.08 (+84.22%) increase
since 10/28/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies